D
Apogee Therapeutics, Inc. APGE
$56.25 $0.210.38% NASDAQ
Recommendation
Prev Close
$56.04
Volume
181,791
Avg Vol (90D)
802,621
Market Cap
$3.67B
Dividend & Yield
--
52-Week Range
$26.20 - $63.50
P/E (TTM)
--
EPS (TTM)
-$4.12
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Apogee Therapeutics (APGE, $56.04) Aroon Indicator entered an Uptrend on October 30, 2025.
10/31/2025 - Tickeron - Stocks
Wall Street Analysts Believe Apogee Therapeutics Inc. (APGE) Could Rally 69.3%: Here's is How to Trade
10/30/2025 - Zacks Investment Research
Apogee Therapeutics (APGE, $55.7) Aroon Indicator entered an Uptrend on October 29, 2025.
10/30/2025 - Tickeron - Stocks
Apogee Therapeutics (APGE, $56.38) Aroon Indicator entered an Uptrend on October 28, 2025.
10/29/2025 - Tickeron - Stocks
Apogee Therapeutics (APGE, $56.23) Aroon Indicator entered an Uptrend on October 27, 2025.
10/28/2025 - Tickeron - Stocks
Apogee Therapeutics' APG777 Study: A Potential Breakthrough in Atopic Dermatitis Treatment
10/27/2025 - TipRanks Financial Blog
Allspring Global Investments Holdings LLC Buys New Stake in Apogee Therapeutics Inc. $APGE
10/26/2025 - MarketBeat
Apogee Therapeutics (NASDAQ:APGE) Receives "Sell (D-)" Rating from Weiss Ratings
10/25/2025 - MarketBeat
Apogee Therapeutics (APGE, $53.32) Aroon Indicator entered an Uptrend on October 24, 2025.
10/25/2025 - Tickeron - Stocks
Apogee Therapeutics (APGE, $53.82) Aroon Indicator entered an Uptrend on October 23, 2025.
10/24/2025 - Tickeron - Stocks
Mizuho Upgrades Apogee Therapeutics (NASDAQ:APGE) to Strong-Buy
10/23/2025 - MarketBeat
Apogee Therapeutics (APGE, $53.48) Aroon Indicator entered an Uptrend on October 22, 2025.
10/23/2025 - Tickeron - Stocks
Apogee Therapeutics (APGE, $55.87) Aroon Indicator entered an Uptrend on October 21, 2025.
10/22/2025 - Tickeron - Stocks
Apogee Therapeutics (NASDAQ:APGE) Earns Outperform Rating from Analysts at Mizuho
10/21/2025 - MarketBeat
Assessing Apogee Therapeutics (APGE) Valuation Following Analyst Optimism on APG777's Clinical Progress
10/21/2025 - Simply Wall St
Apogee Therapeutics (APGE, $56.94) Aroon Indicator entered an Uptrend on October 20, 2025.
10/21/2025 - Tickeron - Stocks
TD Asset Management Inc Sells 6,800 Shares of Apogee Therapeutics Inc. $APGE
10/21/2025 - MarketBeat
Apogee Therapeutics initiated with an Outperform at Mizuho
10/20/2025 - TipRanks Financial Blog
Apogee Therapeutics initiated with bullish view at Mizuho, here's why
10/20/2025 - The Fly
Apogee Therapeutics Inc. (NASDAQ:APGE) Given Consensus Recommendation of "Moderate Buy" by Brokerages
10/19/2025 - MarketBeat
BTIG Maintains a Buy on Apogee Therapeutics (APGE)
10/18/2025 - Insider Monkey
BTIG Maintains a Buy on Apogee Therapeutics (APGE)
10/18/2025 - Yahoo! Finance: News
9 Best Healthcare Stocks with the Highest Upside
10/17/2025 - Insider Monkey
Does Apogee Therapeutics Inc. (APGE) Have the Potential to Rally 72.52% as Wall Street Analysts Expect?
10/14/2025 - Zacks Investment Research
Apogee Therapeutics (APGE) Is Up 31.6% After $300M Equity Offering to Fund R&D Initiatives Has The Bull Case Changed?
10/12/2025 - Simply Wall St
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$270.10M
EBIT (TTM)
-$270.83M
Net Income (TTM)
-$237.67M
Balance Sheet
Total Assets (Q)
$657.77M
Total Debt (Q)
$10.85M
Total Liabilities (Q)
$38.37M
Book Value Per Share (Q)
$10.58
Cash Flow
Cash from Operations (TTM)
-$220.74M
Cash from Investing (TTM)
-$8.90M
Cash from Financing (TTM)
$46.54M
Net Change in Cash (TTM)
-$183.11M
Filings
Filing Date
Monday, August 11, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Loading...
Beta
1.80
7-Day Total Return
5.18%
30-Day Total Return
53.98%
60-Day Total Return
56.25%
90-Day Total Return
30.84%
Year to Date Total Return
19.30%
1-Year Total Return
8.09%
2-Year Total Return
227.42%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 08, 2025 - $26.20
52-week High
Nov 11, 2024 - $63.50
Valuation
Market Cap
$3.67B - Mid Cap
Enterprise Value
$3.06B
Price/Sales (TTM)
--
Price/Book (Q)
5.30
Dividends and Shares
Shares Outstanding
58.43
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.apogeetherapeutics.com
Phone Number
650 394 5230
Address
Building 17
Suite 102b - 221 Crescent Street
Waltham, MA 02453
Country
United States
Year Founded
2022
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic... more
NASDAQ 10/31/2025 1:51PM Eastern Quotes delayed